AstraZeneca Pharma India Limited (NSE: ASTRAZEN), ISIN INE203A01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ASTRAZEN last traded at ₹8268.30 (+1.09%), with a 52-week range of ₹7630.00 to ₹9850.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 75.00%, FIIs 2.68%, DIIs 6.08%, mutual funds 6.01%.
EquiSense Score (ECS): 58/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.